SEC 13F Intelligence

Turning Point Therapeutics Inc

CUSIP 90041T108

Turning Point Therapeutics Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 101.8K shares worth $3M as of Q4 2022. The largest reported holders are Norges Bank, Manufacturers Life Insurance Company, The, and Metlife Investment Management, LLC.

Institutional Holders
1
Q4 2022
Reported Value
$3M
Ticker
unmapped
private placement or foreign
Quarters Tracked
5

Ownership Trend

Institutional holders
Q2 ’19: 50Q2 ’19Q3 ’19: 81Q3 ’19Q2 ’21: 174Q2 ’21Q4 ’21: 155Q4 ’21Q4 ’22: 1Q4 ’22filingsflow.com
Total reported value
Q2 ’19: $3.0BQ2 ’19Q3 ’19: $7.4BQ3 ’19Q2 ’21: $5.9BQ2 ’21Q4 ’21: $4.7BQ4 ’21Q4 ’22: $3MQ4 ’22filingsflow.com

Holders

Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
MetLife Investment Management, LLC$19.6B AUM0.01%$782,44312.1KQ1 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE$116.3B AUM0.00%$1M50.3KQ2 2023OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.